Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
MGP Ingredients
MGPI
$379M
| $3.17M | ﹤0.01% |
86,389
+4,327
| +5% | +$155K |
|
|
TECX
2252
Tectonic Therapeutic
TECX
$529M
| $3.17M | ﹤0.01% |
15,138
+2,521
| +20% | +$519K |
|
2253
Zentalis Pharmaceuticals
ZNTL
$337M
| $3.16M | ﹤0.01% |
+65,805
| New | +$2.52M |
|
|
WCN
2254
Waste Connections
WCN
$42.2B
| $3.16M | ﹤0.01% |
33,668
-3,874
| -10% | -$345K |
|
2255
Univest Financial
UVSP
$1.22B
| $3.16M | ﹤0.01% |
195,570
+12,247
| +7% | +$196K |
|
|
BFYT
2256
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $3.15M | ﹤0.01% |
154,023
+89,994
| +141% | +$1.91M |
|
|
UMH
2257
UMH Properties
UMH
$1.29B
| $3.15M | ﹤0.01% |
243,562
+12,323
| +5% | +$149K |
|
2258
QCR Holdings
QCRH
$1.69B
| $3.15M | ﹤0.01% |
100,991
+6,276
| +7% | +$181K |
|
2259
Ennis
EBF
$552M
| $3.15M | ﹤0.01% |
173,344
-95,462
| -36% | -$1.68M |
|
|
BPYU
2260
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $3.14M | ﹤0.01% |
315,252
-50,593
| -14% | -$509K |
|
2261
Tidewater
TDW
$3.73B
| $3.13M | ﹤0.01% |
559,909
+72,777
| +15% | +$413K |
|
2262
Progyny
PGNY
$2.44B
| $3.12M | ﹤0.01% |
120,968
+55,127
| +84% | +$1.27M |
|
|
NPKI
2263
NPK International
NPKI
$1.06B
| $3.12M | ﹤0.01% |
1,397,467
+112,312
| +9% | +$190K |
|
|
PAE
2264
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $3.12M | ﹤0.01% |
+325,804
| New | +$2.9M |
|
2265
Option Care Health
OPCH
$3.45B
| $3.11M | ﹤0.01% |
223,897
+18,500
| +9% | +$245K |
|
|
TGI
2266
DELISTED
Triumph Group
TGI
| $3.09M | ﹤0.01% |
342,491
+28,385
| +9% | +$210K |
|
2267
Revolution Medicines
RVMD
$39.9B
| $3.08M | ﹤0.01% |
97,531
+67,650
| +226% | +$2.13M |
|
2268
Health Catalyst
HCAT
$154M
| $3.08M | ﹤0.01% |
105,459
+34,240
| +48% | +$946K |
|
2269
Origin Bancorp
OBK
$1.69B
| $3.07M | ﹤0.01% |
139,440
+14,458
| +12% | +$297K |
|
|
VSLR
2270
DELISTED
VIVINT SOLAR, INC.
VSLR
| $3.06M | ﹤0.01% |
309,362
+30,856
| +11% | +$222K |
|
2271
Harmonic Inc
HLIT
$1.25B
| $3.06M | ﹤0.01% |
644,109
+56,857
| +10% | +$318K |
|
|
MFGP
2272
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $3.04M | ﹤0.01% |
555,035
| – | – |
|
2273
GrafTech
EAF
$175M
| $3.04M | ﹤0.01% |
38,078
+1,976
| +5% | +$148K |
|
|
BDSI
2274
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $3M | ﹤0.01% |
687,998
+10,102
| +1% | +$45.4K |
|
|
BWIN
2275
Baldwin Insurance Group
BWIN
$2.69B
| $2.98M | ﹤0.01% |
172,568
+58,085
| +51% | +$701K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.